Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS (unaudited)

v2.4.0.8
CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS (unaudited) (USD $)
In Thousands, except Per Share data, unless otherwise specified
3 Months Ended 9 Months Ended
Sep. 30, 2014
Sep. 30, 2013
Sep. 30, 2014
Sep. 30, 2013
Revenues:        
License and collaborative fees $ 2,450 $ 1,574 $ 4,615 $ 2,578
Contract and other 2,686 4,738 9,903 20,339
Total revenues 5,136 6,312 14,518 22,917
Operating expenses:        
Research and development 20,235 18,198 61,371 51,905
Selling, general and administrative 5,354 5,225 15,768 13,429
Restructuring 0 112 84 209
Total operating expenses 25,589 23,535 77,223 65,543
Loss from operations (20,453) (17,223) (62,705) (42,626)
Other (expense) income, net:        
Interest expense (1,060) (1,159) (3,295) (3,495)
Other income (expense), net 1,393 (132) 1,332 92
Revaluation of contingent warrant liabilities 5,721 (11,125) 33,685 (25,745)
Net loss before taxes (14,399) (29,639) (30,983) (71,774)
Provision for income tax benefit 0 15 0 15
Net loss (14,399) (29,624) (30,983) (71,759)
Basic net loss per share of common stock (in shares) $ (0.13) $ (0.34) $ (0.29) $ (0.85)
Diluted net loss per share of common stock (in shares) $ (0.17) $ (0.34) $ (0.55) $ (0.85)
Shares used in computing basic net loss per share of common stock (in shares) 107,208 87,033 106,768 84,205
Shares used in computing diluted net loss per share of common stock 114,323 87,033 114,876 84,205
Other comprehensive loss:        
Net loss (14,399) (29,624) (30,983) (71,759)
Net unrealized (loss) gain on available-for-sale securities (2) 0 5 0
Comprehensive loss $ (14,401) $ (29,624) $ (30,978) $ (71,759)